Global RNA-based Biopharmaceuticals Sales Market Report 2021

1 RNA-based Biopharmaceuticals Market Overview

• 1.1 RNA-based Biopharmaceuticals Product Scope
• 1.2 RNA-based Biopharmaceuticals Segment by Type
  • 1.2.1 Global RNA-based Biopharmaceuticals Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Therapeutics
  • 1.2.3 Vaccines
• 1.3 RNA-based Biopharmaceuticals Segment by Application
  • 1.3.1 Global RNA-based Biopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Cancer
  • 1.3.3 Diabetes
  • 1.3.4 Tuberculosis
  • 1.3.5 Cardiovascular Diseases
  • 1.3.6 Others
• 1.4 RNA-based Biopharmaceuticals Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global RNA-based Biopharmaceuticals Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global RNA-based Biopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global RNA-based Biopharmaceuticals Price Trends (2016-2027)

2 RNA-based Biopharmaceuticals Estimates and Forecasts by Region

• 2.1 Global RNA-based Biopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global RNA-based Biopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global RNA-based Biopharmaceuticals Sales Market Share by Region (2016-2021)
  • 2.2.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2016-2021)
• 2.3 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global RNA-based Biopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
  • 2.4.2 Europe RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
  • 2.4.3 China RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
  • 2.4.4 Japan RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
  • 2.4.6 India RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)

3 Global RNA-based Biopharmaceuticals Competition Landscape by Players

• 3.1 Global Top RNA-based Biopharmaceuticals Players by Sales (2016-2021)
• 3.2 Global Top RNA-based Biopharmaceuticals Players by Revenue (2016-2021)
• 3.3 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA-based Biopharmaceuticals as of 2020)
• 3.4 Global RNA-based Biopharmaceuticals Average Price by Company (2016-2021)
• 3.5 Manufacturers RNA-based Biopharmaceuticals Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global RNA-based Biopharmaceuticals Market Size by Type

• 4.1 Global RNA-based Biopharmaceuticals Historic Market Review by Type (2016-2021)
  • 4.1.1 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
  • 4.1.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global RNA-based Biopharmaceuticals Price by Type (2016-2021)
• 4.2 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Type (2022-2027)
  • 4.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Type (2022-2027)

5 Global RNA-based Biopharmaceuticals Market Size by Application

• 5.1 Global RNA-based Biopharmaceuticals Historic Market Review by Application (2016-2021)
  • 5.1.1 Global RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
  • 5.1.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global RNA-based Biopharmaceuticals Price by Application (2016-2021)
• 5.2 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Application (2022-2027)
  • 5.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Application (2022-2027)

6 North America RNA-based Biopharmaceuticals Market Facts & Figures

• 6.1 North America RNA-based Biopharmaceuticals Sales by Company
  • 6.1.1 North America RNA-based Biopharmaceuticals Sales by Company (2016-2021)
  • 6.1.2 North America RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
• 6.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Type
  • 6.2.1 North America RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
• 6.3 North America RNA-based Biopharmaceuticals Sales Breakdown by Application
  • 6.3.1 North America RNA-based Biopharmaceuticals Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Application (2022-2027)

7 Europe RNA-based Biopharmaceuticals Market Facts & Figures

• 7.1 Europe RNA-based Biopharmaceuticals Sales by Company
  • 7.1.1 Europe RNA-based Biopharmaceuticals Sales by Company (2016-2021)
  • 7.1.2 Europe RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
• 7.2 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type
  • 7.2.1 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
• 7.3 Europe RNA-based Biopharmaceuticals Sales Breakdown by Application
  • 7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China RNA-based Biopharmaceuticals Market Facts & Figures

• 8.1 China RNA-based Biopharmaceuticals Sales by Company
  • 8.1.1 China RNA-based Biopharmaceuticals Sales by Company (2016-2021)
  • 8.1.2 China RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
• 8.2 China RNA-based Biopharmaceuticals Sales Breakdown by Type
  • 8.2.1 China RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
  • 8.2.2 China RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
• 8.3 China RNA-based Biopharmaceuticals Sales Breakdown by Application
  • 8.3.1 China 168 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 168 Sales Breakdown by Application (2022-2027)

9 Japan RNA-based Biopharmaceuticals Market Facts & Figures

• 9.1 Japan RNA-based Biopharmaceuticals Sales by Company
  • 9.1.1 Japan RNA-based Biopharmaceuticals Sales by Company (2016-2021)
  • 9.1.2 Japan RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
• 9.2 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type
  • 9.2.1 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
• 9.3 Japan RNA-based Biopharmaceuticals Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia RNA-based Biopharmaceuticals Market Facts & Figures

• 10.1 Southeast Asia RNA-based Biopharmaceuticals Sales by Company
  • 10.1.1 Southeast Asia RNA-based Biopharmaceuticals Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
• 10.2 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type
  • 10.2.1 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India RNA-based Biopharmaceuticals Market Facts & Figures

• 11.1 India RNA-based Biopharmaceuticals Sales by Company
  • 11.1.1 India RNA-based Biopharmaceuticals Sales by Company (2016-2021)
  • 11.1.2 India RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
• 11.2 India RNA-based Biopharmaceuticals Sales Breakdown by Type
  • 11.2.1 India RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
  • 11.2.2 India RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
• 11.3 India RNA-based Biopharmaceuticals Sales Breakdown by Application
  • 11.3.1 India RNA-based Biopharmaceuticals Sales Breakdown by Application (2016-2021)
  • 11.3.2 India RNA-based Biopharmaceuticals Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in RNA-based Biopharmaceuticals Business

• 12.1 Pfizer
  • 12.1.1 Pfizer Corporation Information
  • 12.1.2 Pfizer Business Overview
  • 12.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
  • 12.1.5 Pfizer Recent Development
• 12.2 Roche
  • 12.2.1 Roche Corporation Information
  • 12.2.2 Roche Business Overview
  • 12.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Roche RNA-based Biopharmaceuticals Products Offered
  • 12.2.5 Roche Recent Development
• 12.3 Sanofi-Aventis
  • 12.3.1 Sanofi-Aventis Corporation Information
  • 12.3.2 Sanofi-Aventis Business Overview
  • 12.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Products Offered
  • 12.3.5 Sanofi-Aventis Recent Development
• 12.4 Abbott Laboratories
  • 12.4.1 Abbott Laboratories Corporation Information
  • 12.4.2 Abbott Laboratories Business Overview
  • 12.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Products Offered
  • 12.4.5 Abbott Laboratories Recent Development
• 12.5 Arrowhead Pharmaceuticals
  • 12.5.1 Arrowhead Pharmaceuticals Corporation Information
  • 12.5.2 Arrowhead Pharmaceuticals Business Overview
  • 12.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
  • 12.5.5 Arrowhead Pharmaceuticals Recent Development
• 12.6 Benitec Biopharma
  • 12.6.1 Benitec Biopharma Corporation Information
  • 12.6.2 Benitec Biopharma Business Overview
  • 12.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Products Offered
  • 12.6.5 Benitec Biopharma Recent Development
• 12.7 Calimmune Inc
  • 12.7.1 Calimmune Inc Corporation Information
  • 12.7.2 Calimmune Inc Business Overview
  • 12.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Calimmune Inc RNA-based Biopharmaceuticals Products Offered
  • 12.7.5 Calimmune Inc Recent Development
• 12.8 Dicerna
  • 12.8.1 Dicerna Corporation Information
  • 12.8.2 Dicerna Business Overview
  • 12.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Dicerna RNA-based Biopharmaceuticals Products Offered
  • 12.8.5 Dicerna Recent Development
• 12.9 Gradalis
  • 12.9.1 Gradalis Corporation Information
  • 12.9.2 Gradalis Business Overview
  • 12.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Gradalis RNA-based Biopharmaceuticals Products Offered
  • 12.9.5 Gradalis Recent Development
• 12.10 Quark
  • 12.10.1 Quark Corporation Information
  • 12.10.2 Quark Business Overview
  • 12.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Quark RNA-based Biopharmaceuticals Products Offered
  • 12.10.5 Quark Recent Development
• 12.11 RXi
  • 12.11.1 RXi Corporation Information
  • 12.11.2 RXi Business Overview
  • 12.11.3 RXi RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 RXi RNA-based Biopharmaceuticals Products Offered
  • 12.11.5 RXi Recent Development
• 12.12 Senesco
  • 12.12.1 Senesco Corporation Information
  • 12.12.2 Senesco Business Overview
  • 12.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Senesco RNA-based Biopharmaceuticals Products Offered
  • 12.12.5 Senesco Recent Development
• 12.13 Silence Therapeutics
  • 12.13.1 Silence Therapeutics Corporation Information
  • 12.13.2 Silence Therapeutics Business Overview
  • 12.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Products Offered
  • 12.13.5 Silence Therapeutics Recent Development
• 12.14 Silenseed
  • 12.14.1 Silenseed Corporation Information
  • 12.14.2 Silenseed Business Overview
  • 12.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Silenseed RNA-based Biopharmaceuticals Products Offered
  • 12.14.5 Silenseed Recent Development
• 12.15 Tekmira
  • 12.15.1 Tekmira Corporation Information
  • 12.15.2 Tekmira Business Overview
  • 12.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Tekmira RNA-based Biopharmaceuticals Products Offered
  • 12.15.5 Tekmira Recent Development
• 12.16 Alnylam Pharmaceuticals
  • 12.16.1 Alnylam Pharmaceuticals Corporation Information
  • 12.16.2 Alnylam Pharmaceuticals Business Overview
  • 12.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
  • 12.16.5 Alnylam Pharmaceuticals Recent Development

13 RNA-based Biopharmaceuticals Manufacturing Cost Analysis

• 13.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals
• 13.4 RNA-based Biopharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 RNA-based Biopharmaceuticals Distributors List
• 14.3 RNA-based Biopharmaceuticals Customers

15 Market Dynamics

• 15.1 RNA-based Biopharmaceuticals Market Trends
• 15.2 RNA-based Biopharmaceuticals Drivers
• 15.3 RNA-based Biopharmaceuticals Market Challenges
• 15.4 RNA-based Biopharmaceuticals Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List